top of page
Search

NeuCyte Licenses Its Novel Neuronal Programming Technology to Enable Academic Research

  • Dec 6, 2022
  • 2 min read

SUNNYVALE, Calif., Dec. 3, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced that it has entered a license agreement with Boston Children's Hospital. As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to manufacture transcription factor Ngn2 programmed induced neurons. The hospital intends to use this technology for internal research, teaching and educational purposes, and to perform services to other academic institutions.


"We are pleased to license this advantageous technology that was originated from Dr. Thomas Südhof's laboratory at Stanford University," said Mustafa Sahin, MD, PhD, director of the Translational Neuroscience Center and Human Neuron Core at Boston Children's and professor of neurology at Harvard Medical School. "We hope this technology will enable us and other researchers to create a tool that closely resembles human biology in vitro and will become an important part of our effort to improve human health."


"NeuCyte has the exclusive rights to Stanford's original neuronal induction technology and has further developed it to incorporate into our proprietary in vitro drug discovery platforms," said Jonathan Davila, PhD, Co-founder and CEO of NeuCyte. "We are happy to get the technology into the hands of Boston Children's Hospital where it can be further used for academic research. We also welcome discussions with other organizations who are interested in this technology."



About NeuCyte, Inc. NeuCyte is an innovative biotechnology company focused on developing impactful medicines for improving the lives of patients suffering from neurological disorders. Based on its proprietary SynFire® technology for generating human induced pluripotent stem cell (iPSC)-derived induced neural cells, NeuCyte has developed a highly functional in vitro platform for target identification and validation, efficacy testing, neurotoxicity assessment, and disease modeling. With the vast knowledge brought by its staff and scientific advisory board, NeuCyte is actively pursuing drug discovery programs for the treatment of Fragile X Syndrome, Epilepsy, ALS and more. 


Contact: Ji Wu 1230 Bordeaux Drive Sunnyvale, CA 94089 ji.wu@neucyte.com

 
 
 

22 Comments


Stive Joy
Stive Joy
7 days ago

I found the part about Neucyte licensing its neuronal programming technology for academic research especially interesting, mainly because it could make advanced neuron modeling more accessible outside large commercial labs. It’s not often you see biotech companies opening up tools in a way that may encourage broader scientific collaboration. I was reading this while taking a short break from some notes shared through New Assignment Help Australia, and the discussion around neurodegenerative disease research genuinely caught my attention. In a different context, I also came across Assignment Help Australia resources discussing how biotechnology topics are becoming more common in university research projects lately.

Like

chaer christiane
chaer christiane
May 20

Mình có lần lướt đọc mấy trao đổi trên mạng شيخ روحاني thì thấy nhắc nên cũng tò mò mở ra xem thử cho biết. Mình không tìm hiểu sâu جلب الحبيب chỉ xem qua trong thời gian ngắn để quan sát bố cục جلب الحبيب cách sắp xếp شيخ روحاني các mục và trình bày nội شيخ روحاني dung tổng thể. Cảm giác là các phần được trình bày khá gọn, các شيخ روحاني mục rõ ràng nên đọc lướt cũng không bị rối Berlinintim, với mình như شيخ روحاني vậy là đủ để nắm   tin cơ bản rồi. جلب الحبيب

,


Like

jackquelle rabella
jackquelle rabella
Apr 06

Understanding quantity surveyor course helps individuals gain the knowledge needed to work effectively in construction project management roles. UNICCM explains these concepts in a clear and practical way. This improves job readiness.


Like

funded firm
funded firm
Mar 26

Fundedfirm stands out as a reliable choice for traders aiming to work with the Best Prop Firm in Indonesia. It offers a clean structure with fair evaluation steps and quick access to capital for those who perform well. The platform focuses on steady progress, giving traders the freedom to trade with confidence. Clear guidelines and timely payouts create a smooth experience, making it easier to stay focused on results and grow consistently in Indonesia’s active trading market.

Like

toootaa1210
Feb 12

Detailed and practical, this guide explains concrete rebar in a way that feels approachable without oversimplifying. The step by step clarity is especially useful for readers new to the subject. I recently came across a construction related explanation on https://hurenberlin.com that offered a similar level of clarity, and this article fits right in with that quality. Great شيخ روحاني resource. explanation feels practical for everyday rauhane users. I checked recommended tools on https://www.eljnoub.com

s3udy

q8yat

elso9

Like
bottom of page